Yahoo Web Search

Search results

  1. en.m.wikipedia.org › wiki › Anne_WojcickiAnne Wojcicki - Wikipedia

    Anne E. Wojcicki (/ w uː ˈ tʃ ɪ t s k i / woo-CHITS-kee; born July 28, 1973) is an American entrepreneur who co-founded and is CEO of the personal genomics company 23andMe. She founded the company in 2006 with Linda Avey and Paul Cusenza.

  2. www.forbes.com › profile › anne-wojcickiAnne Wojcicki - Forbes

    Jun 1, 2023 · Anne Wojcicki is the cofounder and CEO of 23andMe, a pioneering direct-to-consumer genetics testing firm based in South San Francisco, California. In June 2021, 23andMe went public in...

  3. May 20, 2021 · Anne Wojcicki, CEO of 23andMe, spent a decade in healthcare and biotechnology before launching the DNA testing and analysis company in 2006. Her goal was twofold: to help individuals learn more...

  4. Anne Wojcicki. CEO and Co-Founder. Anne co-founded 23andMe in 2006, three years after the first human genome was sequenced. Her goal was audacious: to help people access, understand, and benefit from the human genome and fundamentally change healthcare in the process.

  5. Apr 10, 2020 · Anne Wojcicki: ‘This is the way the world is going’. As chief executive of 23andMe, she holds the key to a vast genetic database. What will she do with it? Hannah Kuchler. April 10 2020. Stay...

  6. Mar 17, 2023 · Anne, Susan and Janet Wojcicki all have high-powered careers, from running companies like YouTube and 23andMe to being a doctor and professor. Here's their secret.

  7. Anne Wojcicki (born July 28, 1973, San Mateo county, California) is an American entrepreneur and cofounder and chief executive officer of the personal genetics company 23andMe. Wojcicki received a B.S. degree (1996) in biology from Yale University.

  8. Jun 17, 2021 · Anne Wojcicki, the cofounder and CEO of 23andMe, owns 99.4 million shares of the merged company; with shares trading on the Nasdaq under the ticker “ME” at $13.40 as of 3:00pm EDT...

  9. Nov 7, 2023 · 23andMe CEO Anne Wojcicki’s vision for changing healthcare as a ‘full-fledged biotech’. 23andMe always had bigger aims than at-home genetics testing. In this in-depth interview, the company’s founder explains its foray into pharma, drug R&D, solving cold cases and more. Published Nov. 7, 2023. By Alexandra Pecci.

  10. View Anne Wojcickis profile on LinkedIn, a professional community of 1 billion members. Experience: 23andMe · Location: Mountain View · 500+ connections on LinkedIn.

    • 23andMe
  1. People also search for